NMR in pharmaceutical sciences
著者
書誌事項
NMR in pharmaceutical sciences
(eMagRes books)
Wiley, 2015
- タイトル別名
-
Nuclear magnetic resonance in pharmaceutical sciences
大学図書館所蔵 全3件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Other editors: Robin K. Harris, John C. Lindon, Ian D. Wilson
Includes bibliographical references and index
内容説明・目次
内容説明
NMR in Pharmaceutical Sciences is intended to be a comprehensive source of information for the many individuals that utilize MR in studies of relevance to the pharmaceutical sector. The book is intended to educate and inform those who develop and apply MR approaches within the wider pharmaceutical environment, emphasizing the toolbox that is available to spectroscopists and radiologists.
This book is structured on the key processes in drug discovery, development and manufacture, but underpinned by an understanding of fundamental NMR principles and the unique contribution that NMR (including MRI) can provide. After an introductory chapter, which constitutes an overview, the content is organised into five sections. The first section is on the basics of NMR theory and relevant experimental methods. The rest follow a sequence based on the chronology of drug discovery and development, firstly 'Idea to Lead' then 'Lead to Drug Candidate', followed by 'Clinical Development', and finally 'Drug Manufacture'. The thirty one chapters cover a vast range of topics from analytical chemistry, including aspects involved in regulatory matters and in the prevention of fraud, to clinical imaging studies.
Whilst this comprehensive volume will be essential reading for many scientists based in pharmaceutical and related industries, it should also be of considerable value to a much wider range of academic scientists whose research is related to the various aspects of pharmaceutical R for them it will supply vital understanding of pharmaceutical industrial concerns and the basis of key decision making processes.
About eMagRes Handbooks
eMagRes (formerly the Encyclopedia of Magnetic Resonance) publishes a wide range of online articles on all aspects of magnetic resonance in physics, chemistry, biology and medicine. The existence of this large number of articles, written by experts in various fields, is enabling the publication of a series of eMagRes Handbooks on specific areas of NMR and MRI. The chapters of each of these handbooks will comprise a carefully chosen selection of eMagRes articles. In consultation with the eMagRes Editorial Board, the eMagRes handbooks are coherently planned in advance by specially-selected Editors, and new articles are written to give appropriate complete coverage. The handbooks are intended to be of value and interest to research students, postdoctoral fellows and other researchers learning about the scientific area in question and undertaking relevant experiments, whether in academia or industry.
Have the content of this handbook and the complete content of eMagRes at your fingertips!
Visit: www.wileyonlinelibrary.com/ref/eMagRes
目次
Contributors xi
Series Preface xvii
Preface xix
Part A: Introduction 1
1 Drug Discovery and Development: The Role of NMR
Jeremy R. Everett 3
Part B: NMR Theory & Experimental Methods 21
2 Modern NMR Pulse Sequences in Pharmaceutical R&D
John A. Parkinson 23
3 Experimental NMR Methods for Pharmaceutical Research and Development
Anthony C. Dona 41
4 19F NMR Spectroscopy: Applications in Pharmaceutical Studies
John C. Lindon and Ian D. Wilson 53
5 Quantitative NMR Spectroscopy in Pharmaceutical R&D
Ulrike Holzgrabe 63
6 High-throughput NMR in Pharmaceutical R&D
John C. Hollerton 79
7 Multivariate Data Analysis Methods for NMR-based Metabolic Phenotyping in Pharmaceutical and Clinical Research
Kirill A. Veselkov, James S. McKenzie, and Jeremy K. Nicholson 89
Part C: Idea to Lead 103
8 The Role of NMR in Target Identification and Validation for Pharmaceutical R&D
Krishna Saxena and Harald Schwalbe 105
9 High-resolution MAS NMR of Tissues and Cells
Leo L. Cheng 117
10 NMR Studies of Inborn Errors of Metabolism
Sarantos Kostidis and Emmanuel Mikros 131
11 NMR-based Structure Confirmation of Hits and Leads in Pharmaceutical R&D
Philip J. Sidebottom 147
12 Fragment-based Drug Design Using NMR Methods
Leonor Puchades-Carrasco and Antonio Pineda-Lucena 155
13 Hit Discovery from Natural Products in Pharmaceutical R&D
Olivia Corcoran 173
Part D: Lead to Drug Candidate 183
14 NMR-based Structure Determination of Drug Leads and Candidates
Torren M. Peakman 185
15 Mixture Analysis in Pharmaceutical R&D Using Hyphenated NMR Techniques
Ian D. Wilson and John C. Lindon 197
16 Conformation and Stereochemical Analysis of Drug Molecules
Gary J. Sharman 207
17 NMR Methods for the Assignment of Absolute Stereochemistry of Bioactive Compounds
Jose M. Seco and Ricardo Riguera 221
18 Applications of Preclinical MRI/MRS in the Evaluation of Drug Efficacy and Safety
Thomas M. Bocan, Lauren Keith, and David M. Thomasson 255
19 Practical Applications of NMR Spectroscopy in Preclinical Drug Metabolism Studies
Raman Sharma and Gregory S. Walker 267
20 Preclinical Drug Efficacy and Safety Using NMR Spectroscopy
Muireann Coen and Ian D. Wilson 281
21 Characterization of Pharmaceutical Compounds by Solid-state NMR
Frederick G. Vogt 297
22 Structure-based Drug Design Using NMR
Mark Jeeves, Lee Quill, and Michael Overduin 317
23 Pharmaceutical Technology Studied by MRI
David G. Reid and Stephen J. Byard 331
Part E: Clinical Development 345
24 NMR-based Metabolic Phenotyping for Disease Diagnosis and Stratification
Beatriz Jimenez 347
25 NMR-based Pharmacometabonomics: A New Approach to Personalized Medicine
Jeremy R. Everett 359
26 Clinical MRI Studies of Drug Efficacy and Safety
David G. Reid, Paul D. Hockings, and Nadeem Saeed 373
27 The Role of NMR in the Protection of Intellectual Property in Pharmaceutical R&D
Frederick G. Vogt 385
Part F: Drug Manufacture 395
28 Analysis of Counterfeit Medicines and Adulterated Dietary Supplements by NMR
Myriam Malet-Martino and Robert Martino 397
29 Pharmaceutical Industry: Regulatory Control and Impact on NMR Spectroscopy
Andrea Ruggiero and Sarah K. Branch 413
30 NMR Spectroscopy in the European and US Pharmacopeias
Helen Corns and Sarah K. Branch 425
31 NMR in Pharmaceutical Manufacturing
Edwin Kellenbach and Paulo Dani 441
Index 453
「Nielsen BookData」 より